| Literature DB >> 14759259 |
Kathleen Marchal1, Sigrid De Keersmaecker, Pieter Monsieurs, Nadja van Boxel, Karen Lemmens, Gert Thijs, Jos Vanderleyden, Bart De Moor.
Abstract
BACKGROUND: The PmrAB (BasSR) two-component regulatory system is required for Salmonella typhimurium virulence. PmrAB-controlled modifications of the lipopolysaccharide (LPS) layer confer resistance to cationic antibiotic polypeptides, which may allow bacteria to survive within macrophages. The PmrAB system also confers resistance to Fe3+-mediated killing. New targets of the system have recently been discovered that seem not to have a role in the well-described functions of PmrAB, suggesting that the PmrAB-dependent regulon might contain additional, unidentified targets.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14759259 PMCID: PMC395753 DOI: 10.1186/gb-2004-5-2-r9
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583
Figure 1Consensus sequence of the PmrA box. Motif logo representing the initial motif model used to screen the S. typhimurium intergenic sequences.
List of the putative PmrAB targets in S. typhimurium
| Name | Description | Score | Instance | Alignment | Footprint | Distribution (COG) | Distribution [ |
| Minus strand | |||||||
| Putative nitric oxide reductase | 0.848436 | CTTAATGTTTTCTTAAT | / | / | 1000 | All | |
| Pseudogene; frameshift; putative RBS for | 0.814252 | TTTTAGATTCACTTAAT | / | / | 1000 | Some or all | |
| Paralog of | 0.806962 | TTTAATATTCACTTAAA | / | / | 1000 | Some | |
| Putative cytoplasmic protein; putative RBS for | 0.801641 | CTTAATTTTTACTTATT | / | / | 1000 | All | |
| Gifsy-2 prophage | 0.791616 | CTTATTGTTAAGTCAAT | / | / | 1000 | Other distributions | |
| 0.788548 | CAAAACATTAACTTAAT | / | / | 1000 | Subspecies 1 only? | ||
| 0.781719 | CTCAGAATTAACTTAAT | m | + | 1100 | All nine genomes | ||
| 0.780204 | CTTGATATCATCTTAAT | / | / | Subspecies 1 only | |||
| Putative cytoplasmic protein; putative RBS for | 0.772846 | CTTAATACTCACATTAT | / | / | 1000 | Other distributions | |
| Putative imidazolonepropionase and related amidohydrolases; putative RBS for | 0.771153 | GTGAATGTTAAATTAAT | / | / | 1000 | Some or all | |
| 0.769839 | CTTAATGTAGAGTTTAT | m | + | 1110 | All | ||
| 0.766748 | CTTGATGGTAATTTAAC | m | - | 1110 | All nine genomes | ||
| 0.765950 | CTTATTATTCCCTTAAG | / | / | 1000 | All nine genomes | ||
| 0.765889 | TTCAATATTAACATAAT | / | / | 1000 | All nine genomes | ||
| 0.765754 | ATTTAGGATAATTTAAT | nd | / | 1110 | All nine genomes | ||
| Putative cytoplasmic protein | 0.764036 | TTTAACCTTAATTTAAT | nd | / | 1100 | Some | |
| Putative cytoplasmic protein | 0.762904 | ATTAATAGTCACTTATT | / | / | 1000 | Subspecies 1 only? | |
| 0.761166 | CTTAATGTCGAATGAAT | m | + | 1111 | All nine genomes | ||
| 0.760685 | TTTAACATTAACATAAT | m | + | 1110 | All nine genomes? | ||
| Paralog of | 0.759519 | CTTATTATTCACATAAC | / | / | 1000 | Some or all | |
| 0.754895 | CTCAATGTTAACTACTT | / | / | 1000 | All nine genomes? | ||
| Hypothetical protein Fels-1 prophage | 0.754468 | CGTAAGGCTCTTTTAAT | / | / | 1000 | Some | |
| 0.753228 | ATTAAGAATAAATTAAT | / | / | 1000 | Other distributions | ||
| Plus strand | |||||||
| 0.930146 | CTTAAGGTTCACTTAAT | m | + | 1111 | All nine genomes | ||
| 0.913666 | CTTAATATTAACTTAAT | m | + | 1100 | All nine genomes | ||
| 0.912660 | CTTAATGTTAATTTAAT | m | + | 1111 | All nine genomes? | ||
| Putative chorismate mutase; intergenic shared with | 0.888478 | CTTAATGTTATCTTAAT | / | / | 1000 | All | |
| Paralog of | 0.814773 | CTTGATGTTGATTTAAT | / | / | 1000 | All | |
| 0.810981 | CTTTAAGGTTAATTTAA | m | + | 1111 | All nine genomes | ||
| Hypothetical protein putative cytoplasmic protein; located downstream of pathogenicity island 1 | 0.803712 | CTTAATATCAATATAAT | / | / | 1000 | Other distributions | |
| 0.796967 | TTGAATATTAATTTAAT | nd | / | 1110 | All nine genomes? | ||
| 0.791181 | TTTAATTTTAACTTATT | / | / | 1000 | All nine genomes? | ||
| 0.790879 | CTTAATAGTTTCTTAAT | m | + | 1100 | Other distributions | ||
| Putative cytoplasmic protein Putative RBS for | 0.790699 | CCTAATGTTCACTTTTT | / | / | 1000 | Some or all | |
| Putative cytoplasmic protein; shared intergenic with | 0.789514 | TTTCATATTCATTTAAT | / | / | 1000 | Some | |
| 0.788778 | ATTAATATAAATTTAAT | nd | / | 1100 | All nine genomes? | ||
| 0.779808 | TTTAAGGGTAGCTTAAT | m | - | 1111 | All nine genomes | ||
| 0.776490 | ATTAATGTTAACTTTTT | m | - | 1111 | All nine genomes | ||
| Paralog of | 0.774271 | ATTAATGTTACTTTAGT | nd | / | 1100 | Subspecies 1 only | |
| 0.773644 | CTTAGTCTTCATTTGAT | / | / | 1000 | Other distributions | ||
| Lytic enzyme; intergenic shared with | 0.773462 | CTTAATGATTATTTATT | / | / | 1000 | ? | |
| Paralog of | 0.772053 | ATTAATGTCCATTTAGT | / | / | 1000 | ||
| 0.770547 | TTTAATGTTAATTTCTT | m | - | 1111 | All nine genomes | ||
| Putative citrate-sodium symport; intergenic shared with | 0.767968 | CTCATGGTTCATTGAAT | nd | / | 1110 | Other distributions | |
| 0.766758 | CCTAATTTTGACTTTAT | m | + | 1111 | All nine genomes | ||
| 0.767099 | CTTTATGTTTATTTTAT | m | + | 1111 | All nine genomes | ||
| 0.765418 | CTTTATGTTATTTAAAT | nd | / | 1110 | Other distributions | ||
| 0.764452 | ATTAGTGTATACTTAAT | m | + | 1111 | All nine genomes? | ||
| 0.764191 | TTTATTGTTCATATAAT | m | + | 1100 | All nine genomes | ||
| putative arylsulfate sulfotransferase | 0.763003 | TCTAATATTTATTTAAT | nd | / | 1100 | Subspecies 1 only? | |
| 0.762241 | ATCAATTTTAATTTAAT | / | / | 1000 | Some | ||
| 0.760841 | CAGAAGGTTAACTAGAT | m | + | 1111 | All nine genomes | ||
| 0.760004 | ATTAATATTAAATGAAT | m | - | 1111 | All nine genomes | ||
| 0.759514 | ATTAAAATTCACTTTAT | m | + | 1111 | All nine genomes | ||
| 0.758303 | CTTAAGAAATATTTAAT | / | / | 1000 | Some | ||
| 0.756990 | CTTAGGTTTAACAGAAT | m | + | 1111 | All nine genomes | ||
| 0.756938 | CATACTGTACACTTAAA | m | + | 1111 | All nine genomes | ||
| Putative outer membrane protein; Homolog of | 0.756369 | CATTAGGTGCTCTTAAT | / | / | 1000 | Some | |
| 0.754265 | ATTAGTATTAATTTAAC | m | + | 1111 | All nine genomes? | ||
| 0.754063 | CATTTTCTTAACTTAAT | m | - | 1100 | All nine genomes | ||
| 0.753257 | CAAAATATCAATTTAAT | m | - | 1111 | Other distributions |
Name: name of the gene in the S. typhimurium genome (NC_003197). For genes that are divergently transcribed and have a shared intergenic region, the gene for which the motif is detected on the plus strand is indicated first and the gene for which the motif is on the minus strand is indicated after the slash. Description: annotation of the encoded proteins and genome location of the genes (derived from GenBank and Sanger annotation). Score: normalized score assigned to the respective motifs by MotifLocator. Site: instance of the motif as detected in the respective intergenic sequence. Distribution (COG): distribution of the protein as determined by our analysis. The distribution is indicated by a binary profile that indicates the presence 1 versus absence 0 of the protein in species (serovars) of, respectively, Salmonella, E. coli, Shigella and Yersinia (for example, 1111 indicates protein present in all four species; 1000: protein present in Salmonella species only). Distribution: distribution of the protein encoded by the corresponding gene in nine bacterial genomes as determined by McClelland et al. [38]. Proteins having close homologs in at least one Salmonella strain but not in E. coli or K. pneumoniae are indicated by 'some Salmonella only'. Genes that contain close homologs in all genomes are indicated by 'all nine genomes'. Other combinations are indicated by 'other distributions'. ? indicates that the authors were not certain about the statement. Differences between the distribution as determined by McClelland et al. and the one determined by our analysis is due to the difference in selection criteria used to identify close homologs (see Materials and methods). Alignment: indicates whether the intergenic regions in the dataset could be locally aligned (nd, no local alignment detected that contained the original sequence of S. typhimurium; m, local alignment detected. If the dataset only contained homologs from Salmonella species, local alignments were considered noninformative (indicated by /)). Footprint: denotes whether the PmrA motif is conserved in the close homologs. +, the retrieved putative PmrA motif is conserved; -, the intergenic sequences of the orthologs could be locally aligned but the PmrA motif was not part of the conserved regions. Most promising PmrAB targets that contained a PmrA motif matching the PmrA consensus (Figure 4) are in bold face. PmrA motifs that are experimentally validated in this study are indicated by an asterisk.
Figure 2Local alignments of the most promising targets. Examples of local alignments obtained by phylogenetic footprinting of known PmrAB targets and of some promising potential targets. Known motifs or (putative) PmrA motifs are indicated by a box. (a) yfbE (pmrH); (b) yjdB (pmrC); (c) ugd; (d) yibD; (e) ybjG (mig-13); (f) STM1269 (aroQ); (g) sseJ.
Expression analysis of the GFP reporter fusions
| Fusion | Strain | 10 mM MgCl2 | 10 μM MgCl2 | 100 μM FeCl3 | 10 mM MgCl2 100 μM FeCl3 | 10 μM MgCl2 100 μM FeCl3 |
| 6.06 (0.18) | 16.8 (1.42) | 70.53 (3.84) | 27.39 (4.41) | 83.2 (3.21) | ||
| 1.00 (0.01) | 1.02 (0.02) | 1.08 (0.03) | 1.03 (0.03) | 1.16 (0.12) | ||
| 6.17 (1.55) | 13.50 (2.02) | 35.81 (4.67) | 17.86 (5.04) | 49.23 (5.43) | ||
| 2.69 (0.11) | 4.32 (0.48) | 5.2 (0.09) | 2.67 (0.16) | 9.64 (1.19) | ||
| 2.32 (0.22) | 20.39 (1.54) | 19.39 (0.53) | 4.38 (0.19) | 19.48 (2.07) | ||
| 1.06 (0.02) | 1.09 (0.02) | 1.71 (0.09) | 1.02 (0.01) | 1.09 (0.03) | ||
| 1.25 (0.02) | 1.67 (0.26) | 33.35 (7.01) | 27.52 (5.64) | 52.46 (8.98) | ||
| 1.26 (0.02) | 1.21 (0.06) | 1.30 (0.02) | 1.14 (0.02) | 1.81 (0.44) | ||
| 7.68 (1.55) | 11.25(1.46) | 22.58 (1.01) | 3.80 (1.13) | 8.03 (1.27) | ||
| 5.64 (0.72) | 8.72 (1.05) | 7.35 (1.55) | 2.99 (0.43) | 6.47 (1.36) |
All experiments were performed twice. Values indicate the average mean peak fluorescence measurements of at least three samples for the populations grown under the conditions indicated for one representative experiment. Values in parentheses represent standard deviations. All values are expressed in arbitrary units. Strains used: WT = ATCC14028s and pmrA- = pmrA::Tn10d. For pmrC, aroQ, mig-13 and yibD, values represented in the table correspond to experiments performed at pH 7.7. Similar results were obtained at pH 5.8 (data not shown). For sseJ, values correspond to experiments performed at pH 5.8 because at this pH the overall measured expression was higher. The constitutive gfp fusion (pFPV25.1) varied less than 10% between the conditions tested.
Figure 3Site-directed mutagenesis of the PmrA box in yibD. (a) Construction of six species of the yibD promoter mutant, designated pCMPG5615 to pCMPG5620, each with a single base substitution (T → G or A → C) in the PmrA box. Promoters were fused to GFP and promoter activity was assessed by FACS analysis. (b) Plot of the normalized expression values of the six mutant fusions and the wild-type fusion measured in two distinct conditions in the wild type and pmrA::Tn10d mutant background. Gray bars represent condition 1 (pH 7.7, 100 μM FeCl3 + 10 μM MgCl2), white bars correspond to the expression values observed in condition 2 (pH 7.7, 100 μM FeCl3 + 10 mM MgCl2). w, wild-type background; m, pmrA::Tn10d mutant background. The pmrC::GFP fusion was included as a positive control. Bars represent the standard deviations of three independent measurements.
Figure 4Refined consensus of the PmrA box. (a) Alignment of all experimentally verified PmrA sites ([15] or this work) in S. typhimurium [1]. PmrA sites in the orthologs of these respective experimentally verified genes are also displayed if these PmrA motif instances deviated from the PmrA motif in S. typhimurium. (b) An adapted motif model of the PmrA site was built (represented by its logo) on the basis of the sequences represented in (a).
Bacterial strains
| Strain or plasmid | Relevant genotype | Reference or source | |
| ATCC 14028s | Wild type | ATCC | |
| JSG421 | [ | ||
| LB5010 | [ | ||
| DH5α | Fφ80Δ | Gibco BRL | |
| Plasmids | pCRII-TOPO | Cloning vector, AmpR | Invitrogen |
| pFPV25 | ColE1 | [ | |
| pFPV25.1 | Constitutive | [ | |
| pCMPG5611 | pFPV25 with | This work | |
| pCMPG5612 | pFPV25 with | This work | |
| pCMPG5613 | pFPV25 with | This work | |
| pCMPG5614 | pFPV25 with | This work | |
| pCMPG5621 | pFPV25 with | This work | |
| pCMPG5615 | pCMPG5611 with point mutated putative PmrA motif C→A | This work | |
| pCMPG5616 | pCMPG5611 with point mutated putative PmrA motif T→G | This work | |
| pCMPG5617 | pCMPG5611 with point mutated putative PmrA motif T→G | This work | |
| pCMPG5618 | pCMPG5611 with point mutated putative PmrA motif A→C | This work | |
| pCMPG5619 | pCMPG5611 with point mutated putative PmrA motif A→C | This work | |
| pCMPG5620 | pCMPG5611 with point mutated putative PmrA motif T→C | This work | |
Primers used to construct the GFP promoter fusions
| Name | Sequence 5' to 3' | Description |
| Amplification of promoter regions | ||
| Pro-115 | Amplification of | |
| Pro-116 | Amplification of | |
| Pro-117 | Amplification of | |
| Pro-118 | Amplification of | |
| Pro-119 | Amplification of | |
| Pro-120 | Amplification of | |
| Pro-121 | Amplification of | |
| Pro-122 | Amplification of | |
| Pro-224 | Amplification of | |
| Pro-225 | Amplification of | |
Restriction sites in the primers are indicated in bold type.